Since 2014, Vancouver Nanomedicine Day has advanced nanomedicine research, knowledge mobilization and commercialization in Canada by sharing high-impact findings and facilitating networking—among researchers, postdoctoral fellows, graduate students, and life science and startup biotechnology companies—to catalyze research collaboration.
In its first Scientific Meeting, the recently established Nanomedicines Innovation Network (NMIN) gathered its pan-Canadian teams of experts and other stakeholders to advance:
NMIN’s plans to support innovative new research and commercialization strategies for nanomedicines development and uptake within the healthcare system;
NMIN’s efforts to build capacity in the next generation of nanomedicine researchers and entrepreneurs to strengthen Canada’s position as a global leader in nanomedicines innovation; and
networking and collaboration among researchers, clinicians, trainees, industry and government.
In its first Scientific Meeting, the recently established Nanomedicines Innovation Network (NMIN) gathered its pan-Canadian teams of experts and other stakeholders to advance:
NMIN’s plans to support innovative new research and commercialization strategies for nanomedicines development and uptake within the healthcare system;
NMIN’s efforts to build capacity in the next generation of nanomedicine researchers and entrepreneurs to strengthen Canada’s position as a global leader in nanomedicines innovation; and
networking and collaboration among researchers, clinicians, trainees, industry and government.